Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
MEDIUM RISK
Score updated Oct 13, 2026

DNTH — Dianthus Therapeutics, Inc. Dilution Risk Tracker

Track DNTH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DNTH — Get alerts when the score changes →

As of October 13, 2026, Dianthus Therapeutics, Inc. (DNTH) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Dianthus Therapeutics, Inc. has a market capitalization of $4.56B, 55.93M shares outstanding, 243 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $600.00M, ATM program capacity of $100.10M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 19%
💰 Capital Raise model 38%
• Active shelf registration ($600M, 13% of market cap)
• Active ATM program with $100M remaining capacity
🔔 Track DNTH — Get forecast alerts →

Market Data

Market Cap$4.56B
Shares Outstanding55.93M
Float54.60M
Cash$886.81M
Debt$1.36M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore29/100DilutionWatch score record
Shares Outstanding55.93MVerified float table or market cache
Public Float54.60MVerified float table or market cache
Market Cap$4.56BMarket data cache
Cash Runway99.4 monthsDilutionWatch score inputs
Shelf Capacity$600.00MSEC-derived dilution fields
ATM Capacity$100.10MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 40.5% shares (2026Q1 vs prior)
243 institutional holders · 69.42M shares
#1 FMR LLC 7.77M shares
#2 Avidity Partners Management LP 4.21M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.06M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.14M
Days to Cover8.3
% of Float16.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-09
xbrl XBRL CONVERTIBLE 2025-03-11
4 INSIDER TRANSACTION 2026-03-13
4 INSIDER TRANSACTION 2026-03-13
4 INSIDER TRANSACTION 2026-03-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DNTH Dilution Snapshot

Dianthus Therapeutics, Inc. (DNTH) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DNTH's DilutionScore is currently 29/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 41/100 (Medium risk).

Period Score Risk Level Duration
Sep 09 – Oct 13, 202629/100MEDIUM35 days
Jul 16 – Sep 08, 202641/100MEDIUM54 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DNTH shares outstanding have increased 26.5% from 43.22M (Mar 2026) to 54.67M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202654.67M54.60M▲ 5.78%
May 10, 202654.67M51.62M▲ 0.02%
May 08, 202654.67M51.60M▲ 22.93%
Apr 18, 202654.45M41.98M▲ 0.16%
Mar 20, 202643.22M41.91M▼ 0.13%
Mar 17, 202643.22M41.96M▲ 0.13%
Mar 14, 202643.22M41.91M▲ 7.26%
Mar 11, 202643.22M39.07M▲ 4.14%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DNTH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DNTH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DNTH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DNTH
DNTH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.